Please assess the completion status of the following clinical trial:

Trial Title: Effect of Deep Neuromuscular Block on Surgical Conditions in Morbidly Obese Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* ASA I-III~* BMI \> 34 kg/m2~* Elective bariatric surgery.~Exclusion Criteria:~* Known or suspected neuromuscular disorders impairing neuromuscular function~* Allergies to muscle relaxants, anesthetics or narcotics~* A(family) history of malignant hyperthermia~* Women who are or may be pregnant or are currently breast feeding~* Renal insufficiency, as defined by serum creatinine x 2 of normal, or urine output \< 0.5 ml/kg/h for at least 6 h.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- moderate neuromuscular block (Type: ACTIVE_COMPARATOR): rocuronium 0.1-0.6 mg/kg aimed at a train of four of 1 - 2 twitches
- deep neuromuscular block (Type: EXPERIMENTAL): rocuronium 0.1-0.6 mg/kg aimed at a post tetanic count of 1 - 2 twitches

Based on this trial design, predict the completion outcome and termination type (if applicable).